Adoptive transfer of p50‐deficient immature myeloid cells (p50‐IMC), generated from either p50‐null mice or via gene editing, impedes the growth of murine neuroblastoma, dependent upon the presence of T cells and MHC‐mediated antigen presentation. This evidence concerns the gene NFKB1 and neuroblastoma.